16
Jan
http://www.facebook.com/events/121302214705174/
Why not support help us have more treatment options? 

Online Email Campaign- per ME Advocate Robert Miller



URGENT: ME/CFS Patient “A C T I ON” for Patients, Family and Friends Organizers: Robert Miller Patient/Advocate, Cort Johnson (Health Rising), Billie Moore Patient Advocate and TeamContact: 511bobmiller42@gmail.com On December 20th, ME/CFS patients rose to the Challenge and Sent in 750 personal testimonies to the FDA Advisory Committee, requesting for Ampligen approval. 30 Patients, family and clinicians testified. The final vote was split, the panel will recommend to FDA to not approve Ampligen on 3 questions, but voted Yes, that Ampligen’s safety profile is adequate for approval on a 4th question . So We Must “ACT”. This ACTION will be emailing the contacts below Everyday until FDA approval. We deserve treatment Now. The Final decision date is February 2nd , but it could come any day. We all need to start emailing Today and Everyday. (The template below is for you to follow, you can just copy and paste for ease.) Email Contacts Are: HHS Secretary Katherine Sebelius, FDA Commissioner Margaret Hamburg, Director Janet Woodcock, Deputy Director Sandra Kweder, Senator Richard Blumenthal, Senator Kay Hagen, Congressman Joseph Pitts_________________________________________________________From: PLACE YOUR EMAIL ADDRESS HERE To:Kathleen.Sebelius@hhs.gov,margaret.hamburg@fda.hhs.gov,janet.woodcock@fda.hhs.gov, Sandra.Kweder@fda.hhs.gov,Monica.volante@mail.house.gov,CC:Karen_Wade@hagan.senate.gov,Eamonn_Hart@blumenthal.senate.gov, 511bobmiller42@gmail.com Subject: Approve Ampligen Now ———————————————————————————————————————————From: PLACE YOUR NAME HEREThe FDA should approve Ampligen by Feb 2, 2013. The advisory committee voted that Ampligen’s safety profile is adequate for approval. Patients and our physicians must have the opportunity to access a treatment that has shown such promise for ME/CFS patients. Failure to do so will leave us with no FDA approved options to treat this disease.The FDA has stated that ME/CFS is a serious and life threatening disease. Yet, without treatment, patients and their families are left to suffer. Many of us are bedbound or homebound. We are in constant pain and suffering, abandoned to bodies that torture us every day and demands that we parse out our activities like a single piece of bread that must last for a month. According to a DePaul study, patients are more likely to die prematurely from cancer, heart failure or suicide. This is the long-term reality of living, untreated, with ME/CFS. Imagine living with an untreatable disease so terrible that you would choose suicide to escape it.750 written and over 30 in-person patient testimonies, including that of the AAC patient representative, conveyed how this devastating disease impacts our lives and the imperative of weighing the opportunity to benefit against the risk of no treatment to escape from this terrible physical burden and get back even a piece of our lives.For us, even small improvements have a very significant impact on our quality of life, which were dismissed by FDA statisticians. It’s evident that Ampligen has provided benefit to patients, with the testimony and data pointing to meaningful change in our ability to function and care for ourselves. The true nature of this disease and the plight of patients have been ignored for too long. Patient testimony and patient and clinician experience provide evidence that this drug works in many patients. A number of AAC members agreed that Ampligen helps and other members noted that they saw an indication of effectiveness in some patients. Let patients and their doctors decide whether the only treatment in FDA clinical trials for ME/CFS is the right medicine to provide relief from the living death that is our reality today. Remember that the disease itself has a collateral impact that creates its own serious risks for patients.The advisory committee voted that Ampligen’s safety profile is adequate for approval.Approve Ampligen by Feb 2, 2013. Anything less is condemning ME/CFS patients to years more of continued suffering without any hope of relief.Just Do it!

http://www.facebook.com/events/121302214705174/

Why not support help us have more treatment options? 

  • Online Email Campaign- per ME Advocate Robert Miller
  • image
    URGENT: ME/CFS Patient “A C T I ON” for Patients, Family and Friends 

    Organizers: Robert Miller Patient/Advocate, Cort Johnson (Health Rising), Billie Moore Patient Advocate and Team
    Contact: 511bobmiller42@gmail.com 

    On December 20th, ME/CFS patients rose to the Challenge and Sent in 750 personal testimonies to the FDA Advisory Committee, requesting for Ampligen approval. 30 Patients, family and clinicians testified. The final vote was split, the panel will recommend to FDA to not approve Ampligen on 3 questions, but voted Yes, that Ampligen’s safety profile is adequate for approval on a 4th question . 

    So We Must “ACT”. This ACTION will be emailing the contacts below Everyday until FDA approval. We deserve treatment Now. The Final decision date is February 2nd , but it could come any day. We all need to start emailing Today and Everyday. 

    (The template below is for you to follow, you can just copy and paste for ease.) 

    Email Contacts Are: 
    HHS Secretary Katherine Sebelius, FDA Commissioner Margaret Hamburg, Director Janet Woodcock, Deputy Director Sandra Kweder, Senator Richard Blumenthal, Senator Kay Hagen, Congressman Joseph Pitts
    _________________________________________________________
    From: PLACE YOUR EMAIL ADDRESS HERE 
    To:Kathleen.Sebelius@hhs.gov,margaret.hamburg@fda.hhs.gov,janet.woodcock@fda.hhs.gov, Sandra.Kweder@fda.hhs.gov,Monica.volante@mail.house.gov,
    CC:Karen_Wade@hagan.senate.gov,Eamonn_Hart@blumenthal.senate.gov, 511bobmiller42@gmail.com 
    Subject: Approve Ampligen Now 

    ———————————————————————————————————————————
    From: PLACE YOUR NAME HERE
    The FDA should approve Ampligen by Feb 2, 2013. The advisory committee voted that Ampligen’s safety profile is adequate for approval. Patients and our physicians must have the opportunity to access a treatment that has shown such promise for ME/CFS patients. Failure to do so will leave us with no FDA approved options to treat this disease.

    The FDA has stated that ME/CFS is a serious and life threatening disease. Yet, without treatment, patients and their families are left to suffer. Many of us are bedbound or homebound. We are in constant pain and suffering, abandoned to bodies that torture us every day and demands that we parse out our activities like a single piece of bread that must last for a month. According to a DePaul study, patients are more likely to die prematurely from cancer, heart failure or suicide. This is the long-term reality of living, untreated, with ME/CFS. Imagine living with an untreatable disease so terrible that you would choose suicide to escape it.

    750 written and over 30 in-person patient testimonies, including that of the AAC patient representative, conveyed how this devastating disease impacts our lives and the imperative of weighing the opportunity to benefit against the risk of no treatment to escape from this terrible physical burden and get back even a piece of our lives.
    For us, even small improvements have a very significant impact on our quality of life, which were dismissed by FDA statisticians. It’s evident that Ampligen has provided benefit to patients, with the testimony and data pointing to meaningful change in our ability to function and care for ourselves. 

    The true nature of this disease and the plight of patients have been ignored for too long. Patient testimony and patient and clinician experience provide evidence that this drug works in many patients. A number of AAC members agreed that Ampligen helps and other members noted that they saw an indication of effectiveness in some patients. 
    Let patients and their doctors decide whether the only treatment in FDA clinical trials for ME/CFS is the right medicine to provide relief from the living death that is our reality today. Remember that the disease itself has a collateral impact that creates its own serious risks for patients.

    The advisory committee voted that Ampligen’s safety profile is adequate for approval.
    Approve Ampligen by Feb 2, 2013. Anything less is condemning ME/CFS patients to years more of continued suffering without any hope of relief.

    Just Do it!
8
Dec
Give the gift of health. It’s priceless and shows you care. I adore Pro-Health products because I always know I’m getting a quality supplement geared especially for me as an ME/CFS patient. Check it out when you get a chance: 
ProHealth.com Holiday Gift Ideas

Give the gift of health. It’s priceless and shows you care. I adore Pro-Health products because I always know I’m getting a quality supplement geared especially for me as an ME/CFS patient. Check it out when you get a chance: 

ProHealth.com Holiday Gift Ideas

18
Sep

How much pesticides are in the food you eat? 

The Environmental Working Group analyzed 10 years worth of data from the USDA & US Department of Agriculture to make up their 2012 Shopper’s Guide to Pesticides in Produce. The website even has AP’s for IPhones and Android Devices : http://www.ewg.org/foodnews/guide

Dirty Dozen Plus

Buy these organic. The lower the number the MORE pesticide was found!

1
Apple
Apples
2
Celery
Celery
3
Red Pepper
Sweet bell peppers
4
Peaches
Peaches
5
Strawberries
Strawberries
6
Nectarines
Nectarines
– imported
7
Grapes
Grapes
8
Spinach
Spinach
9
Lettuce
Lettuce
10
Cucumber
Cucumbers
11
Blueberries
Blueberries 
– domestic
12
Potatoe
Potatoes
Plus
+
Green Beans
Green beans
+
Kale
Kale/Greens

+ May contain pesticide residues of special concern

Clean 15
Lowest in Pesticide
1
Onions
Onions
2
Sweet Corn
Sweet Corn
3
Pineapple
Pineapples
4
Avocado
Avocado
5
Cabbage
Cabbage
6
Peas
Sweet peas
7
Asparagus
Asparagus
8
Mango
Mangoes
9
Eggplant
Eggplant
10
Kiwi
Kiwi
11
Cantelope
Cantaloupe 
- domestic
12
Sweet Potatoes
Sweet potatoes
13
Grapefruit
Grapefruit
14
Watermelon
Watermelon
15
Mushrooms
Mushrooms
23
Jun
Is the drug, Rituximab that has helped so many ME patients among the many uninvestigated complaints against the maker?
Are adverse reactions being overlooked?
http://www.reuters.com/article/2012/06/21/us-roche-europe-idUSBRE85K1NH20120621
http://www.fiercepharma.com/story/roche-overlooks-80000-adverse-reaction-complaints/2012-06-21
What happens now?
Please share or reblog.

Is the drug, Rituximab that has helped so many ME patients among the many uninvestigated complaints against the maker?

Are adverse reactions being overlooked?

http://www.reuters.com/article/2012/06/21/us-roche-europe-idUSBRE85K1NH20120621

http://www.fiercepharma.com/story/roche-overlooks-80000-adverse-reaction-complaints/2012-06-21

What happens now?

Please share or reblog.

15
Jun
During The Chronic Fatigue Syndrome Advisory Committee meeting this week, ME/CFS experts,The International Association of Chronic Fatigue Syndrome Myaligic Encephalomyelitis (IACFSME)presented A Primer For Clinical Practioners. Take a look.  
http://www.iacfsme.org/Portals/0/PDF/PrimerFinal3.pdf 


During The Chronic Fatigue Syndrome Advisory Committee meeting this week, ME/CFS experts,The International Association of Chronic Fatigue Syndrome Myaligic Encephalomyelitis (IACFSME)presented A Primer For Clinical Practioners. Take a look.  

30
Apr

May 12th is International NeuroImmune Invisible Disease Awareness Day!

May 12th dot org want you to email them your story, photographs, poems, art, video’s to be put up on the May12thDotOrg YouTube channel 

Contribute your story now to may12globalaction@gmail.com 

We want to be swamped with stories!

Pay It Forward For ME !